This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1996 Feb 17;312(7028):389-90.

doi: 10.1136/bmj.312.7028.389.

Long term adjuvant therapy for primary breast cancer

PMID: 8601097
PMCID: PMC2350071
DOI: 10.1136/bmj.312.7028.389

Editorial

Long term adjuvant therapy for primary breast cancer

R D Bulbrook. BMJ. 1996.

. 1996 Feb 17;312(7028):389-90.

doi: 10.1136/bmj.312.7028.389.

Author

PMID: 8601097
PMCID: PMC2350071
DOI: 10.1136/bmj.312.7028.389

Erratum in

BMJ 1996 Apr 20;312(7037):992

No abstract available

PubMed Disclaimer

Comment in

Adjuvant treatment with tamoxifen. Local research ethics committees should review their approval of prevention trial.
Read C. Read C. BMJ. 1996 Apr 20;312(7037):1036. doi: 10.1136/bmj.312.7037.1036a. BMJ. 1996. PMID: 8616356 Free PMC article. No abstract available.
Adjuvant treatment with tamoxifen. Side effects may have been overstated.
Baum M, Cuzick J. Baum M, et al. BMJ. 1996 Apr 20;312(7037):1036. doi: 10.1136/bmj.312.7037.1036. BMJ. 1996. PMID: 8616357 Free PMC article. No abstract available.
Adjuvant treatment with tamoxifen. Recruitment into studies assessing optimum duration of treatment must continue.
Earl H, Baker P, Kerr D, Lee M, Gray R, Baum M. Earl H, et al. BMJ. 1996 Apr 20;312(7037):1036-7. doi: 10.1136/bmj.312.7037.1036b. BMJ. 1996. PMID: 8616358 Free PMC article. No abstract available.
Adjuvant treatment with tamoxifen. Clinicians must share knowledge with their patients more readily.
Goodare H. Goodare H. BMJ. 1996 Apr 20;312(7037):1037. doi: 10.1136/bmj.312.7037.1037a. BMJ. 1996. PMID: 8616359 Free PMC article. No abstract available.
Adjuvant treatment with tamoxifen. Multicentre trial should be welcomed.
Corder AP. Corder AP. BMJ. 1996 Apr 20;312(7037):1037. doi: 10.1136/bmj.312.7037.1037. BMJ. 1996. PMID: 8616360 Free PMC article. No abstract available.

Similar articles

Aromatase inhibitors in adjuvant therapy of breast cancer: before, instead of, or beyond tamoxifen.
Pritchard KI. Pritchard KI. J Clin Oncol. 2005 Aug 1;23(22):4850-2. doi: 10.1200/JCO.2005.03.904. Epub 2005 Jul 11. J Clin Oncol. 2005. PMID: 16009956 No abstract available.
Aromatase inhibitors as adjuvant therapy for breast cancer: overall survival versus disease-free survival as a primary end point in clinical practice.
Sánchez-Muñoz A, Ribelles N, Márquez A, Pérez-Ruiz E, Alba E. Sánchez-Muñoz A, et al. J Clin Oncol. 2009 Dec 10;27(35):e255-6; author reply e257-8. doi: 10.1200/JCO.2009.25.3914. Epub 2009 Nov 2. J Clin Oncol. 2009. PMID: 19884520 No abstract available.
Efficacy of tamoxifen as treatment of breast cancer.
Powles TJ. Powles TJ. Semin Oncol. 1997 Feb;24(1 Suppl 1):S1-48-S1-54. Semin Oncol. 1997. PMID: 9045315 Review.
Should adjuvant chemotherapy be used in elderly women (> or = 70 years) with breast cancer? Contra.
Di Costanzo F, Gasperoni S, Di Costanzo F. Di Costanzo F, et al. Tumori. 2002 Jan-Feb;88(1 Suppl 1):S91-2. doi: 10.1177/030089160208800128. Tumori. 2002. PMID: 11989939 No abstract available.
Adjuvant tamoxifen: how long before we know how long?
Rea D, Poole C, Gray R. Rea D, et al. BMJ. 1998 May 16;316(7143):1518-9. doi: 10.1136/bmj.316.7143.1518. BMJ. 1998. PMID: 9582148 Free PMC article. Review. No abstract available.

See all similar articles

Cited by

Adjuvant treatment with tamoxifen. Informed consent and follow up in aTTom trial are inadequate.
Cunningham H. Cunningham H. BMJ. 1996 Aug 24;313(7055):494. doi: 10.1136/bmj.313.7055.494. BMJ. 1996. PMID: 8776338 Free PMC article. No abstract available.
Management of primary breast cancer.
Melville A, Liberati A, Grilli R, Sheldon T. Melville A, et al. Qual Health Care. 1996 Dec;5(4):250-8. doi: 10.1136/qshc.5.4.250. Qual Health Care. 1996. PMID: 10164151 Free PMC article. Review. No abstract available.
Adjuvant treatment with tamoxifen. Recruitment into studies assessing optimum duration of treatment must continue.
Earl H, Baker P, Kerr D, Lee M, Gray R, Baum M. Earl H, et al. BMJ. 1996 Apr 20;312(7037):1036-7. doi: 10.1136/bmj.312.7037.1036b. BMJ. 1996. PMID: 8616358 Free PMC article. No abstract available.
Adjuvant treatment with tamoxifen. Side effects may have been overstated.
Baum M, Cuzick J. Baum M, et al. BMJ. 1996 Apr 20;312(7037):1036. doi: 10.1136/bmj.312.7037.1036. BMJ. 1996. PMID: 8616357 Free PMC article. No abstract available.
Adjuvant treatment with tamoxifen. Local research ethics committees should review their approval of prevention trial.
Read C. Read C. BMJ. 1996 Apr 20;312(7037):1036. doi: 10.1136/bmj.312.7037.1036a. BMJ. 1996. PMID: 8616356 Free PMC article. No abstract available.

See all "Cited by" articles

References

1. J Clin Oncol. 1996 Jan;14(1):78-84 - PubMed
1. J Clin Oncol. 1993 Nov;11(11):2090-100 - PubMed
1. Drug Saf. 1993 May;8(5):381-97 - PubMed
1. Acta Oncol. 1992;31(2):251-7 - PubMed
1. Cancer. 1990 Jul 15;66(2):199-205 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information